Built for medical device manufacturers, the Regulatory Intelligence Service turns shifting requirements in the EU, UK, USA, and Canada into practical guidance your team can use immediately.
On 29 June 2026, the European Commission adopted Commission Implementing Regulation (EU) 2026/1451, updating the list of Well-Established Technologies (WETs) eligible for the clinical investigation exemption provided under the Medical Device Regulation (EU) 2017/745 (MDR).
Maytal, an international regulatory consultancy specialising in medical devices, in vitro diagnostics and life sciences, has entered into a strategic partnership with the University of Birmingham's Precision Health Technologies Accelerator (PHTA) to support the next generation of medical technology innovators.
Maytal will be attending Med-Tech Innovation Expo 2026, taking place at the National Exhibition Centre in Birmingham on 3 and 4 June 2026, to develop new collaborations and strengthen partnerships in the UK medical device and regulatory sectors.
Maytal is pleased to announce its participation in the Expodental Meeting in Rimini, Italy, May 14-16, 2026, the leading trade show for the dental industry.
How many regulatory decisions are you making “just to be safe”… instead of strategically?
Under Regulation (EU) 2017/745, we see it every week: companies launching clinical investigations… when they could actually avoid them.